Michael Meißner Selected Research

Serotonin (5 Hydroxytryptamine)

12/2021

Efficacy and adverse events of selective serotonin noradrenaline reuptake inhibitors in the management of postoperative pain: A systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Meißner Research Topics

Disease

3	Postoperative Pain 02/2024 - 01/2021
2	Pain (Aches) 12/2021 - 01/2021
1	Chronic Pain 02/2024
1	Dizziness (Lightheadedness) 12/2021

Drug/Important Bio-Agent (IBA)

1	1,3- bis(4- amidinophenoxy)- 2- (4- amidinophenoxymethyl)ethylpropaneIBA 02/2024
1	Morphine (MS Contin)FDA LinkGeneric 02/2024
1	Opioid Analgesics (Opioids)IBA 02/2024
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2021
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 12/2021
1	Serotonin (5 Hydroxytryptamine)IBA 12/2021
1	PlacebosIBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021

Therapy/Procedure

1	Epidural Analgesia 02/2024